Arcturus Therapeutics
ARCT
$26.63
Share price
0.30%
Change (1 day)
1.95%
Change (1 year)
Arcturus Therapeutics (ARCT) - Cash on Hand
Cash on Hand as of December 2023 : $0.29 B
According to Arcturus Therapeutics
's latest financial reports the company has $0.29 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Arcturus Therapeutics - Cash on Hand chart (from 2012 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.29 B | -25.49% |
| 2022-12-31 | $0.39 B | 5.77% |
| 2021-12-31 | $0.37 B | -19.96% |
| 2020-12-31 | $0.46 B | 548.74% |
| 2019-12-31 | $71.35 M | 94.37% |
| 2018-12-31 | $36.7 M | -24.43% |
| 2017-12-31 | $48.57 M | 482.06% |
| 2016-12-31 | $8.34 M | -83.53% |
| 2015-12-31 | $50.68 M | 133.57% |
| 2014-12-31 | $21.69 M | -56.69% |
| 2013-12-31 | $50.1 M | 51552.58% |
| 2012-12-31 | $0.09 M | -83.04% |
| 2011-12-31 | $0.57 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | $0.13 M | -99.95% | Bahamas |
 NRC Health
NRC | $6.65 M | -97.72% | 🇺🇸 USA |